|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.491
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.427
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.307
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.290
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.251
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.213
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.211
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.181
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.178
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.173
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.167
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.165
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.162
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.160
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.156
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.152
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.141
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.128
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.125
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.123
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.123
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.119
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.112
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.111
|
Mouse |
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.111
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.111
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.108
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.108
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.107
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.105
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.105
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.105
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.104
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.102
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.094
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.094
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.094
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.093
|
Mouse |
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.092
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.091
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.089
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.089
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.089
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.089
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.089
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.088
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.086
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.084
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.084
|
Mouse |
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.082
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.080
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.079
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.077
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.076
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.075
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.075
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.075
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.074
|
Mouse |
|
|
male gamete generation
|
GO:0048232 |
285 |
0.074
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.073
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.073
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.072
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.072
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.072
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.071
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.071
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.071
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.070
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.070
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.070
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.069
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.069
|
Mouse |
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.069
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.069
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.068
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.068
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.068
|
Mouse |
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.068
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.068
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.068
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.067
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.066
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.065
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.064
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.064
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.063
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.063
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.062
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.062
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.062
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.062
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.060
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.060
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.060
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.060
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.059
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.059
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.059
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.059
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.058
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.058
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.058
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.057
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.056
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.056
|
|
|
|
vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure
|
GO:0002025 |
3 |
0.056
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.055
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.055
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.055
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.054
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.053
|
|
|
|
regulation of camp mediated signaling
|
GO:0043949 |
7 |
0.053
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.052
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.052
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.052
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.052
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.051
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.051
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.051
|
|
|
|
peristalsis
|
GO:0030432 |
8 |
0.051
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.051
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.051
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.050
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.050
|
|
|
|
gastrin induced gastric acid secretion
|
GO:0001698 |
1 |
0.050
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.050
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.050
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.050
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.050
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.049
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.049
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.049
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.048
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.048
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.048
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.047
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.047
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.047
|
Mouse |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.047
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.047
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.046
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.046
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.046
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.045
|
Mouse |
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.045
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.045
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.045
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.044
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.044
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.044
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.044
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.043
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.043
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.043
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.042
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.042
|
Mouse |
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.042
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.042
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.041
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.041
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.041
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.041
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.041
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.041
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.041
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.041
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.040
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.040
|
|
|
|
positive regulation of the force of heart contraction by epinephrine norepinephrine
|
GO:0001997 |
3 |
0.040
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.040
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.039
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.039
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.039
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.039
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.039
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.039
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.038
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.038
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.038
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.038
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.038
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.037
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.037
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.036
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.036
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.036
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.036
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.036
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.036
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.036
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.036
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.036
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.035
|
Mouse |
|
|
sclerotome development
|
GO:0061056 |
4 |
0.035
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.035
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.035
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.035
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.035
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.035
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.034
|
|
|
|
negative regulation of g protein coupled receptor protein signaling pathway
|
GO:0045744 |
12 |
0.034
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.034
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.034
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.034
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.034
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.034
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.034
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.033
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.033
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.033
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.033
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.033
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.032
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.032
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.032
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.032
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.032
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.032
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.031
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.031
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.031
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.031
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.031
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.031
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.031
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.031
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.031
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
27 |
0.031
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.030
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.030
|
|
|
|
phospholipase c activating serotonin receptor signaling pathway
|
GO:0007208 |
1 |
0.030
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.030
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.030
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.030
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.030
|
|
|
|
positive regulation of camp biosynthetic process
|
GO:0030819 |
19 |
0.030
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.030
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.030
|
|
|
|
mesendoderm development
|
GO:0048382 |
3 |
0.029
|
|
|
|
positive regulation of the force of heart contraction by chemical signal
|
GO:0003099 |
3 |
0.029
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.029
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.029
|
|
|
|
fear response
|
GO:0042596 |
33 |
0.028
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.028
|
|
|
|
camp mediated signaling
|
GO:0019933 |
15 |
0.028
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.028
|
Mouse |
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.028
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.028
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.028
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.028
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.028
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.028
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.027
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.027
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.027
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.027
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.027
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.027
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.027
|
Mouse |
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.027
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.026
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.026
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.026
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.026
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.026
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.026
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.026
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.026
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.026
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.026
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.026
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.025
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.025
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.025
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.025
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.025
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.025
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.025
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.025
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.025
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.025
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.025
|
|
|
|
regulation of lyase activity
|
GO:0051339 |
13 |
0.025
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.025
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.024
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.024
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.024
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.024
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.024
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.024
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.024
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.024
|
|
|
|
serotonin receptor signaling pathway
|
GO:0007210 |
8 |
0.024
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.024
|
|
|
|
regulation of systemic arterial blood pressure by norepinephrine epinephrine
|
GO:0001993 |
8 |
0.024
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.024
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.023
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.023
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.023
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.023
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.023
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.023
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.023
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.023
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.023
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.023
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.023
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.023
|
|
|
|
response to histamine
|
GO:0034776 |
1 |
0.023
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.023
|
|
|
|
sensitization
|
GO:0046960 |
2 |
0.022
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.022
|
|
|
|
positive regulation of growth hormone secretion
|
GO:0060124 |
3 |
0.022
|
|
|
|
regulation of adenylate cyclase activity
|
GO:0045761 |
10 |
0.022
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.022
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.022
|
|
|
|
respiratory system process
|
GO:0003016 |
25 |
0.022
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.022
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.022
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.022
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.022
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.022
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.022
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.022
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.022
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.022
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.021
|
|
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
2 |
0.021
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.021
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.021
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.021
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.021
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.021
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.021
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.021
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.021
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.021
|
|
|
|
neutrophil mediated killing of gram positive bacterium
|
GO:0070946 |
2 |
0.021
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.021
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.021
|
|
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.021
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.021
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.021
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.021
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.021
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.021
|
|
|
|
negative regulation of purine nucleotide metabolic process
|
GO:1900543 |
16 |
0.021
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.021
|
Mouse |
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.021
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.021
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.021
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.021
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.021
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.021
|
|
|
|
catecholamine uptake
|
GO:0090493 |
4 |
0.020
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.020
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.020
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.020
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.020
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.020
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.020
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
2 |
0.020
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.020
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.020
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.020
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.020
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.020
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.020
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.020
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.020
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.020
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.020
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.020
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.020
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.019
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.019
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.019
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.019
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.019
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.019
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.019
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.019
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.019
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.019
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.019
|
|
|
|
translation
|
GO:0006412 |
93 |
0.019
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.019
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.019
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.019
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.019
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.019
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.019
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.019
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
26 |
0.019
|
|
|
|
regulation of systemic arterial blood pressure by circulatory renin angiotensin
|
GO:0001991 |
13 |
0.019
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.019
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.019
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.019
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.019
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.019
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.019
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.019
|
Mouse |
|
|
dopamine receptor signaling pathway
|
GO:0007212 |
16 |
0.018
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.018
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.018
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.018
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.018
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.018
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.018
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.018
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.018
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.018
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.018
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.018
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.018
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.018
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.018
|
|
|
|
regulation of steroid hormone biosynthetic process
|
GO:0090030 |
4 |
0.018
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.018
|
|
|
|
positive regulation of hormone metabolic process
|
GO:0032352 |
3 |
0.018
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.018
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.018
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.018
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.018
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.018
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.018
|
|
|
|
cellular response to temperature stimulus
|
GO:0071502 |
2 |
0.017
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.017
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.017
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.017
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.017
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.017
|
|
|
|
negative regulation of cyclic nucleotide metabolic process
|
GO:0030800 |
5 |
0.017
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.017
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.017
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.017
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.017
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.017
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.017
|
|
|
|
regulation of hormone metabolic process
|
GO:0032350 |
15 |
0.017
|
|
|
|
negative regulation of adenylate cyclase activity
|
GO:0007194 |
1 |
0.017
|
|
|
|
positive regulation of inositol phosphate biosynthetic process
|
GO:0060732 |
2 |
0.017
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.017
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.017
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.017
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.017
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.017
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.017
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.017
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.017
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.017
|
|
|
|
regulation of cyclase activity
|
GO:0031279 |
13 |
0.017
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.016
|
|
|
|
detection of chemical stimulus involved in sensory perception of smell
|
GO:0050911 |
4 |
0.016
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.016
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.016
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
2 |
0.016
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.016
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.016
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.016
|
|
|
|
negative regulation of protein secretion
|
GO:0050709 |
20 |
0.016
|
|
|
|
interleukin 13 secretion
|
GO:0072611 |
2 |
0.016
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.016
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.016
|
|
|
|
response to cocaine
|
GO:0042220 |
14 |
0.016
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.016
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.016
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.016
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.016
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.016
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.016
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.016
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.016
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.016
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.016
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.016
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.016
|
|
|
|
behavioral response to cocaine
|
GO:0048148 |
10 |
0.015
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.015
|
|
|
|
negative regulation of nucleotide biosynthetic process
|
GO:0030809 |
6 |
0.015
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.015
|
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.015
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.015
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.015
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.015
|
|
|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.015
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.015
|
|
|
|
regulation of g protein coupled receptor protein signaling pathway
|
GO:0008277 |
37 |
0.015
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.015
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.015
|
|
